Page 4 - Japanese (NIKKEI) Growth Pharmaceuticals & Biotech Stocks

UPDATED Nov 27, 2024

Discover Japanese Pharmaceuticals & Biotech Growth Stocks that are on the NIKKEI. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

90 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

4884

Kringle Pharma
JP¥899.002.0%17.8%JP¥6.1bn/aPS76.4xn/an/a

4575

CanBas
JP¥928.006.9%-6.4%JP¥17.7bn/aPB5.5xn/an/a

4576

D. Western Therapeutics Institute
JP¥93.00-17.0%-42.6%JP¥3.5bn/aPS7.6xn/an/a

4582

SymBio Pharmaceuticals
JP¥244.002.5%-2.4%JP¥11.2bn/aPS3.6xn/an/a

6090

Human Metabolome Technologies
JP¥599.00-0.8%-9.4%JP¥3.5bn/aPE14.4xn/a2.5%

2183

Linical
JP¥339.00-1.5%-36.2%JP¥7.7bn/aPB1xn/a4.7%

4889

Renascience
JP¥290.002.1%-35.1%JP¥3.7bn/aPS28.6xn/an/a

4588

Oncolys BioPharma
JP¥684.002.2%13.2%JP¥15.5bn/aPS495.3xn/an/a

4241

atect
JP¥462.000.4%-37.1%JP¥2.0bn/aPB1.2xn/a2.2%

4512

Wakamoto PharmaceuticalLtd
JP¥240.002.6%20.6%JP¥8.4bn/an/an/a1.3%

4539

Nippon Chemiphar
JP¥1,508.000.5%-7.5%JP¥5.4bn/aPB0.3xn/a3.3%

4586

MedRx
JP¥91.00-1.1%-38.9%JP¥4.3bn/aPS16.8xn/an/a

4883

Modalis Therapeutics
JP¥156.0019.1%22.8%JP¥8.8bn/aPB3.5xn/an/a

8095

Astena Holdings
JP¥485.00-2.6%1.3%JP¥19.5bn/aPE9.3xn/a3.7%

7777

3-D Matrix
JP¥114.002.7%-32.5%JP¥11.2bn/aPS2.1xn/an/a

4564

OncoTherapy Science
JP¥31.000%24.0%JP¥8.4bn/aPS17.6xn/an/a

219A

Heartseed
JP¥1,449.007.9%n/aJP¥31.9bn/an/an/an/a

4882

Perseus Proteomics
JP¥744.0010.7%5.7%JP¥11.0bn/aPS100.6xn/an/a
Page 4 of 4
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.